Laurion Capital Management’s Integra LifeSciences IART Stock Holding History

Laurion Capital Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-16,112	Closed	-$757K	–	977
2020 Q2	$757K	Buy	16,112 +7,812	+94%	+$384K	0.01%	526
2020 Q1	$371K	Buy	+8,300	New	+$436K	﹤0.01%	612
2019 Q4	–	Sell	-5,313	Closed	-$319K	–	1029
2019 Q3	$319K	Buy	+5,313	New	+$317K	﹤0.01%	857
2019 Q2	–	Sell	-17,442	Closed	-$972K	–	1017
2019 Q1	$972K	Buy	17,442 +1,991	+13%	+$101K	0.01%	510
2018 Q4	$697K	Buy	+15,451	New	+$848K	0.01%	638
2018 Q3	–	Sell	-22,829	Closed	-$1.47M	–	1346
2018 Q2	$1.47M	Buy	+22,829	New	+$1.41M	0.01%	679
2017 Q4	–	Sell	-23,700	Closed	-$1.2M	–	1658
2017 Q3	$1.2M	Buy	+23,700	New	+$1.22M	0.01%	917
2017 Q2	–	Sell	-11,800	Closed	-$497K	–	1728
2017 Q1	$497K	Buy	+11,800	New	+$504K	﹤0.01%	918

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Laurion Capital Management's IART Position: Q3 2020 in Review

Laurion Capital Management sold out of Integra LifeSciences (IART) in Q3 2020, closing a stake of 16,112 shares — an estimated $757K sold.

Laurion Capital Management first reported a position in IART in Q1 2017 and held it in 8 quarters. The position peaked at $1.47M in Q2 2018. 237 funds tracked by Wall St. Rank hold IART as of Q3 2020.

Laurion Capital Management reported no remaining Integra LifeSciences position as of Q3 2020 after selling out during the quarter.
Laurion Capital Management sold 16,112 Integra LifeSciences shares in Q3 2020, an estimated $757K.
Laurion Capital Management first reported a position in Integra LifeSciences in Q1 2017 and held it in 8 quarters.
Laurion Capital Management's Integra LifeSciences position peaked at $1.47M in Q2 2018.
237 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2020.

Based on Laurion Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.